DESIREE HOLBERT: Open Payments
NPI 1245820232 · MCKINNEY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,953 in 107 payments from 21 companies in 2025. Trend: 2023 $2,929 · 2024 $3,325 · 2025 $1,953
Food & beverage: $1,953
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 13 | $316 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $271 |
| Corium, LLC | 11 | $248 |
| ABBVIE INC. | 19 | $196 |
| Teva Pharmaceuticals USA, Inc. | 4 | $110 |
| Almatica Pharma LLC | 4 | $95 |
| Lundbeck LLC | 5 | $92 |
| Otsuka America Pharmaceutical, Inc. | 4 | $81 |
| Axsome Therapeutics, Inc. | 4 | $72 |
| Vanda Pharmaceuticals Inc. | 3 | $64 |
Products named: INGREZZA, CAPLYTA, Azstarys, VRAYLAR, REXULTI, LOREEV XR, AUSTEDO XR, Auvelity.
Industry payments across TX — which companies pay providers there.
